Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EUR | -0.81% | -2.38% | +2.07% |
04-22 | BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment | MT |
04-11 | Gerresheimer shares down on outlook, but key contracts confirmed | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.07% | 38.68M | |
+9.78% | 7.42B | |
-12.31% | 291M | |
-.--% | 62.2M | |
-14.70% | 56.62M |
- Stock Market
- Equities
- ADMIN Stock
- News Administer Oyj
- Arch Biopartners on Pre-IND Meeting With FDA to Repurpose Cilastatin as New Treatment to Prevent Acute Kidney Injury